Clinical Trials in Nashville

Showing 2101-2120 of 9,711 trials

A Study of ADRX-0706 in Select Advanced Solid Tumors

NCT06036121

The primary purpose of this study is to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0706 in patients with select advanced solid tumors.

Solid TumorsTriple Negative Breast Cancer (TNBC)Urothelial Cancer+1 more

Adcentrx Therapeutics144 participantsStarted Sep 2023

Los Angeles, California, United States • Los Angeles, California, United States • St. Petersburg, Florida, United States +18 more locations

RECRUITING< 1 mile

Lupus Landmark Study: A Prospective Registry and Biorepository

NCT05934149

The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).

Systemic Lupus Erythematosus (SLE)Lupus NephritisNeuropsychiatric Systemic Lupus Erythematosus

Lupus Research Alliance3,500 participantsStarted Jun 2023

Birmingham, Alabama, United States • Tucson, Arizona, United States • Beverly Hills, California, United States +18 more locations

A Study of ADRX-0706 in Select Advanced Solid Tumors

Lupus Landmark Study: A Prospective Registry and Biorepository

Find Trials by Condition in Nashville

Mobilizing Doulas to Empower Black Women in Post-partum Diabetes Prevention

Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Actis Total Hip System 2 Year Follow-up

Efficacy and Safety of Pembrolizumab (MK-3475) With Lenvatinib (E7080/MK-7902) vs. Docetaxel in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease (PD) After Platinum Doublet Chemotherapy and Immunotherapy (MK-7902-008/E7080-G000-316/LEAP-008)

Observational Evaluation of Atopic Dermatitis in Pediatric Patients

Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)

Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients

Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma

Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

A Community-based Assessment of Skin Care, Allergies, and Eczema

Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma

Topical ENS-002 for Atopic Dermatitis in Adults

Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis